CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 21 filers reported holding CHEMBIO DIAGNOSTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $9,000 | -95.8% | 1,500 | -94.2% | 0.02% | -95.3% |
| Q2 2016 | $213,000 | +119.6% | 25,963 | +59.6% | 0.34% | +134.5% |
| Q1 2016 | $97,000 | +203.1% | 16,263 | +146.1% | 0.14% | +291.9% |
| Q2 2015 | $32,000 | -25.6% | 6,608 | -38.2% | 0.04% | -28.8% |
| Q1 2015 | $43,000 | -82.7% | 10,697 | -83.2% | 0.05% | -81.9% |
| Q4 2014 | $249,000 | – | 63,600 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |